By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BrainStorm Cell Therapeutics Inc. 

Tel Aviv      Israel
Phone: n/a Fax:



Company News
BrainStorm Cell's Stem Cell Treatment Stops Disease Progression in 87% of ALS Patients in Phase II Study 1/12/2016 5:36:43 AM
BrainStorm Cell's NurOwn For The Treatment Of ALS Published In JAMA Neurology 1/11/2016 9:59:21 AM
BrainStorm Cell To Conduct Phase 2 Multi-Dose Nurown Trial In ALS At Hadassah Medical Center 1/11/2016 7:27:06 AM
BrainStorm Cell Reschedules Corporate Update Conference Call To January 11, 2016 12/10/2015 9:50:18 AM
BrainStorm Cell Announces Appointment Of Dr. Revital Geffen-Aricha As Vice President Of Research & Development 12/7/2015 8:53:00 AM
BrainStorm Cell And Octane Biotech Announce Success In Cocoon Application Development Based On Customized Bioreactor For NurOwn Stem Cells 12/1/2015 6:50:45 AM
BrainStorm Cell Awarded Additional $735,000 Non-Dilutive Grant For 2015 From Israel's Office Of The Chief Scientist 11/30/2015 7:33:16 AM
BrainStorm Cell Reports Third Quarter 2015 Financial Results And Provides Corporate Update 11/17/2015 9:21:33 AM
BrainStorm Cell Announces Positive DSMB Review In Phase 2 Trial Of NurOwn In ALS 11/9/2015 6:47:04 AM
BrainStorm Cell Strengthens Intellectual Property Position - Granted Patent For Company's NurOwn Technology Platform 10/16/2015 10:07:50 AM